Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.73571 | 31 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.68533 | 30 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.68905 | 30 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.62463 | 30 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.62078 | 29 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.77197 | 31 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.73028 | 30 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.65306 | 29 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.64475 | 29 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.67203 | 30 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.67102 | 30 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.6483 | 30 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.67892 | 30 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.67639 | 30 |